Ex Parte RUSSELL et al - Page 4




          Appeal No. 2001-2048                                                        
          Application 09/357,257                                                      


          would not separate out the triisopropanolamine before using the             
          diphosphite (answer, page 7).  Because bis(2,4-dicumylphenyl)-              
          pentaerythritol diphosphite has not been disclosed as having any            
          utility other than stabilizing polymers, the examiner argues, it            
          is plausible to presume that the triisopropanolamine is innocuous           
          with respect to both bis(2,4-dicumylphenyl)pentaerythritol                  
          diphosphite and polymers (answer, page 6).  The examiner argues             
          that any benefit of the triisopropanolamine observed by the                 
          appellants is merely an inherent characteristic of the                      
          commercially available bis(2,4-dicumylphenyl)pentaerythritol                
          diphosphite/triisopropanolamine blend (answer, pages 6-7).                  
               The examiner’s arguments are directed toward whether one of            
          ordinary skill in the art would have had a reasonable expectation           
          of success in using the commercially available bis(2,4-                     
          dicumylphenyl)pentaerythritol diphosphite/triisopropanolamine               
          blend in the polyolefin compositions of the applied prior art.              
          To establish a prima facie case of obviousness, however, the                
          examiner also must explain how the applied prior art would have             
          provided one of ordinary skill in the art with a motivation to              
          use this blend as proposed by the examiner.  See In re Vaeck, 947           




                                          4                                           





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007